Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
10x Genomics, Inc. Financials Banner

10x Genomics, Inc. Financials

TXG Stock Analysis

Page title

Section title

TXG Income Statement Key Metrics

  • Revenue(TTM)629.74 M
  • Gross Profit(TTM)414.92 M
  • EBITDA(TTM)-131.06 M
  • Net Income(TTM)-182.55 M
  • EPS Diluted(TTM)-1.53

Decode TXG's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

TXG earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of TXG (0.662) is higher than the average of its peers (0.648).

Net Profit Margin vs Peers

Net profit margin ratio of TXG (-0.412) is higher than the average of its peers (-0.955).

TXG Return on Equity

See how efficiently TXG generates profit for it's shareholders.

-34.42%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of TXG (-0.344) is higher than the average of its peers (-0.799).

Return on Equity Growth

TXG's Return on Equity has shown poor growth over the past 10 years, increasing by only -10.91%.

TXG Revenue Growth

See how TXG has grown it's revenue over the past 10 years.


Revenue Growth

TXG's revenue has grown significantly over the past 10 years, increasing by over 36.22%.

TXG FY, 2023 Revenue Breakdown

See how TXG converts it's revenue into profit.

TXG Balance Sheet Health

TXG Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

TXG financial position analysis

Short Term Liabilities

TXG's short term assets($596M) can safely cover it's short term liabilities($127M).

Long Term Liabilities

TXG's short term assets($596M) can safely cover it's long term liabilities($97M).

TXG Debt to Equity